Prospective Grant of Exclusive License: Adult Human Dental Pulp Stem Cells, Postnatal Stem Cells, and Multipotent Postnatal Stem Cells From Human Periodontal Ligament

Riepilogo

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of an exclusive license worldwide to practice the invention embodied in United States issued Patent Number 7,052,907 titled: "Adult Human Dental Pulp Stem Cells in vitro and in vivo" referenced at HHS as E-233-2000/0-US-03 and corresponding foreign patent applications, United States Patent Application Number 10/553,633 titled: "Postnatal Stem Cells and Uses Thereof" referenced at HHS as E-018-2003/0-US-02 and corresponding foreign patent applications, United States Patent Application Number 11/433,627 titled: "Multipotent Postnatal Stem Cells from Human Periodontal Ligament" referenced at DHHS as E-033-2004/0-US-03 and corresponding patent applications, to Angioblast Systems, Inc. having a place of business in the state of New York. The field of use may be limited to the following: FDA or similar foreign body approved therapeutic for (1) regeneration/repair of the periodontal ligament lost from chronic periodontitis, (2) regeneration/repair of dentin/pulp complex lost during deep car